Strong marketing capabilities in the MENA Region

Our powerful combination of quality products and extensive sales and marketing capabilities sets us apart from our competitors in the Middle East and North Africa.
» Find out more about our MENA sales and marketing

A successful research and development team

Our research and development team has particular expertise in developing technically challenging products such as injectables, complex formulations, unstable compounds and sustained release tablets and capsules.
» Find out more about our R&D capabilities

A significant pipeline

We currently have the strongest pipeline we have ever had, with 104 new products pending approval and 133 new products under development.
» Find out more about our product pipeline

A commitment to quality manufacturing

Our multiple manufacturing facilities provide us with the flexibility to select the most appropriate manufacturing strategy for a particular product, taking into account factors such as cost, regulatory requirements and capacity.
» Find out more about our manufacturing capabilities

API sourcing strength

The active pharmaceutical ingredient (”API”) is our key raw material and a significant cost for us. We have relationships with more than 70 API suppliers and are continuously looking for new, lower cost sources of API.
» Find out more about our API sourcing capabilities

A commitment to our people

Since the Company was founded in 1978, a key priority has been investment in employee training and development.
» Find out more about our commitment to our people